Myxoid Leiomyosarcoma of the Uterus in a Patient Receiving Tamoxifen Therapy: A Case Report : International Journal of Gynecological Pathology

Secondary Logo

Journal Logo

Case Reports

Myxoid Leiomyosarcoma of the Uterus in a Patient Receiving Tamoxifen Therapy: A Case Report

Botsis, Dimitris M.D., Ph.D.; Koliopoulos, Carolina M.D., Ph.D.; Kondi-Pafitis, Agathi M.D., Ph.D.; Creatsas, George M.D., Ph.D., F.A.C.S.

Author Information
International Journal of Gynecological Pathology 25(2):p 173-175, April 2006. | DOI: 10.1097/01.pgp.0000185407.93308.ce

Abstract

Summary: 

In this paper, we present a case of myxoid leiomyosarcoma development in a patient receiving tamoxifen for 3 years because of breast cancer. The myxoid leiomyosarcoma should be included in the differential diagnosis of any uterine tumor with a predominantly myxomatous composition. A review of the literature indicates that tamoxifen may increase not only the risk for endometrial cancer but also for uterine sarcoma, suggesting vigilance for uterine cancer in women who are being treated with this drug.

©2006International Society of Gynecological Pathologists

You can read the full text of this article if you:

Access through Ovid